1276175

Shenzhen Hepalink Pharmaceutical Group Co., Ltd. — FEI 3014772595

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
June 13, 2025
Fiscal Year
2025
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Shenzhen (China)